The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
Felicity
F
Daly
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D017954:Africa South of the Sahara; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004338:Drug Combinations; D000068679:Emtricitabine; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage*; D000068698:Tenofovir; D014622:Vaginal Creams, Foams, and Jellies
D044966:Anti-Retroviral Agents; D004338:Drug Combinations; D063065:Organophosphonates; D014622:Vaginal Creams, Foams, and Jellies; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine